Primary Peritoneal Carcinoma Withdrawn Phase Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00551265Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line ChemotherapyTreatment